About this Event
12800 E Montview Blvd
Dr. Kelly Faulk will present on "Targeting the oncogenic driver: trial development utilizing KMT2A-menin inhbition for relapsed/refractory infant KMT2A-rearranged leukemia"
0 people are interested in this event
Please fill out the registration form below to receive the zoom link for virtual attendance.